Literature DB >> 25740602

microRNA-181a enhances cell proliferation in acute lymphoblastic leukemia by targeting EGR1.

Lorena Verduci1, Gianluca Azzalin1, Silvia Gioiosa1, Claudia Carissimi1, Ilaria Laudadio1, Valerio Fulci2, Giuseppe Macino1.   

Abstract

Acute lymphoblastic leukemia (ALL) is an aggressive cancer that occurs in both children and adults. Starting from an integrated analysis of miRNA/mRNA expression profiles in 20 ALL patients, we identify a negative correlation between miR-181a and EGR1. Coherently, miR-181a over-expression in Jurkat T-ALL cells decreases EGR1 expression, increasing cell proliferation and enhancing the cell-cycle progression from G1 to S phase. We show that EGR1 is a new direct target of miR-181a. Our findings suggest that miR-181a behaves as an onco-miRNA in ALL by down-regulating EGR1.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acute lymphoblastic leukemia (ALL); Cell cycle; Cell proliferation; EGR1; miR-181a; onco-miRNA

Mesh:

Substances:

Year:  2015        PMID: 25740602     DOI: 10.1016/j.leukres.2015.01.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  29 in total

1.  Tumor suppression by the EGR1, DMP1, ARF, p53, and PTEN Network.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Cancer Invest       Date:  2018-11-05       Impact factor: 2.176

2.  miR-181a-2 downregulates the E3 ubiquitin ligase CUL4A transcript and promotes cell proliferation.

Authors:  Venkateshwarlu Bandi; Sudhakar Baluchamy
Journal:  Med Oncol       Date:  2017-07-20       Impact factor: 3.064

3.  MiR-150-5p retards the progression of myocardial fibrosis by targeting EGR1.

Authors:  Jie Shen; Wanhong Xing; Fangqi Gong; Wei Wang; Yufeng Yan; Yiying Zhang; Chunhong Xie; Songling Fu
Journal:  Cell Cycle       Date:  2019-05-23       Impact factor: 4.534

4.  MicroRNA-181 contributes to downregulation of SAMHD1 expression in CD4+ T-cells derived from Sèzary syndrome patients.

Authors:  Rebecca Kohnken; Karthik M Kodigepalli; Anjali Mishra; Pierluigi Porcu; Li Wu
Journal:  Leuk Res       Date:  2016-11-17       Impact factor: 3.156

5.  Universal attenuators and their interactions with feedback loops in gene regulatory networks.

Authors:  Dianbo Liu; Luca Albergante; Timothy J Newman
Journal:  Nucleic Acids Res       Date:  2017-07-07       Impact factor: 16.971

Review 6.  The progress of early growth response factor 1 and leukemia.

Authors:  Jing Tian; Ziwei Li; Yang Han; Tao Jiang; Xiaoming Song; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2016-05

Review 7.  P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia.

Authors:  Stefania Trino; Luciana De Luca; Ilaria Laurenzana; Antonella Caivano; Luigi Del Vecchio; Giovanni Martinelli; Pellegrino Musto
Journal:  Front Pharmacol       Date:  2016-12-16       Impact factor: 5.810

Review 8.  MicroRNA expression and activity in T-cell acute lymphoblastic leukemia.

Authors:  Fang Ye
Journal:  Oncotarget       Date:  2017-12-20

Review 9.  The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy.

Authors:  Chengxin Luan; Zixue Yang; Baoan Chen
Journal:  Onco Targets Ther       Date:  2015-10-13       Impact factor: 4.147

10.  Loss of Egr1, a human del5q gene, accelerates BCR-ABL driven chronic myelogenous leukemia.

Authors:  Silvia Maifrede; Andrew Magimaidas; Xiaojin Sha; Kaushiki Mukherjee; Dan A Liebermann; Barbara Hoffman
Journal:  Oncotarget       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.